{"schema_version":"secwatch.filing_event.v1","accession":"0001174947-23-001234","form_type":"8-K","ticker":"CNMD","cik":"0000816956","company_name":"CONMED Corp","filed_at":"2023-10-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:32.082058+00:00","generated_at":"2026-06-09T12:31:22.881226+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"CONMED Q3 sales $304.6M (+10.7% YoY); adj. EPS $0.90 (+16.9%); raises FY guidance","bullets":["Revenue of $304.6M, +10.7% reported (+11.9% constant currency). Domestic +9.5%, International +12.3%.","GAAP diluted EPS $0.50 (vs $1.48); Adjusted diluted EPS $0.90, up 16.9% from $0.77.","General Surgery sales $179.9M (+15% reported); Orthopedic Surgery $124.7M (+5.1%).","Full-year revenue guidance raised to $1.24B-$1.26B; adj. EPS guidance raised to $3.45-$3.55.","Adjusted EBITDA margin 19.6% vs 19.4% prior year."],"urls":{"canonical":"https://secwatch.observer/filing/0001174947-23-001234","json":"https://secwatch.observer/filing/0001174947-23-001234.json","markdown":"https://secwatch.observer/filing/0001174947-23-001234.md","text":"https://secwatch.observer/filing/0001174947-23-001234.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/816956/000117494723001234/0001174947-23-001234-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/816956/000117494723001234/form8k-30967_cnmd.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T12:31:22.881226+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"9b6aa2d170fbb95d9a65229f5415b2e406fc24d7","claim":"CONMED Corp updated its the third quarter ended September 30, 2023 guidance (reaffirmed).","evidence_excerpt":"On October 25, 2023, CONMED Corporation issued a press release announcing financial results for the third quarter ended September 30, 2023.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/816956/000117494723001234/0001174947-23-001234-index.htm","confidence":0.5,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the third quarter ended September 30, 2023"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}